Capitolis Liquid Global Markets’s Regeneron Pharmaceuticals REGN Stock Holding History

Capitolis Liquid Global Markets’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.8M	Hold	75,000	–	–	0.2%	88
2026 Q1	$57.9M	Sell	75,000 -5,000	-6%	-$3.83M	0.37%	57
2025 Q4	$61.7M	Buy	80,000 +5,000	+7%	+$3.4M	0.37%	61
2025 Q3	$42.2M	Sell	75,000 -93,000	-55%	-$52.6M	0.34%	57
2025 Q2	$88.2M	Buy	168,000 +117,000	+229%	+$65.3M	0.65%	35
2025 Q1	$32.3M	Sell	51,000 -36,000	-41%	-$24.8M	0.29%	61
2024 Q4	$62M	Buy	87,000 +49,000	+129%	+$41.1M	0.6%	40
2024 Q3	$39.9M	Hold	38,000	–	–	0.42%	46
2024 Q2	$39.9M	Hold	38,000	–	–	0.49%	46
2024 Q1	$36.6M	Buy	+38,000	New	+$36.1M	0.59%	42

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capitolis Liquid Global Markets's REGN Position: Q2 2026 in Review

Capitolis Liquid Global Markets held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 75,000 shares worth $46.8M. The position accounts for 0.2% of the portfolio, ranked #88.

Capitolis Liquid Global Markets first reported a position in REGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $88.2M in Q2 2025. 1,334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Capitolis Liquid Global Markets held 75,000 shares of Regeneron Pharmaceuticals worth $46.8M as of Q2 2026.
Capitolis Liquid Global Markets left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.2% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #88 holding.
Capitolis Liquid Global Markets first reported a position in Regeneron Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Capitolis Liquid Global Markets's Regeneron Pharmaceuticals position peaked at $88.2M in Q2 2025.
1,334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.